Table 2 Clinical and laboratory results of the fresh ICSI procedures.
Group I (No r-LH) | Group II (r-LH) | p-value | |
|---|---|---|---|
Patients (n) | 122 | 122 | |
Cycles (n) | 122 | 122 | |
Transfers (n) | 114 | 119 | |
Total dose r-FSH (IU) | 2181 ± 719 | 2032 ± 651 | ns |
Total dose r-LH (IU) | ------ | 1048 ± 262 | |
Retrieved oocytes (n) | 9.3 ± 4.7 | 10.9 ± 5.9 | 0.036 |
Immature oocytes (n) | 2.6 ± 2.7 | 2.4 ± 2.8 | ns |
Metaphase II oocytes (n) | 6.7 ± 4.1 | 8.5 ± 4.6 | 0.0014 |
Fertilization rate | 66.2% | 71.1% | 0.017 |
Embryos/cycle(n) | 5.4 ± 3.7 | 6.5 ± 3.0 | 0.0092 |
Embryos transferred(n) | 2.0 ± 0.8 | 2.0 ± 0.5 | ns |
Frozen embryos/cycle(n) | 3.0 ± 3.6 | 4.4 ± 3.8 | 0.0008 |
Implantation rate | 17.9% | 23.2% | ns |
Pregnancy rate | |||
-per patient | 29.5% | 33.6% | ns |
-per transfer | 31.6% | 34.4% | ns |
Miscarriage rate | 11.1% | 14.6% | ns |
Live birth/patient (or started cycle) | 23.8% | 27.0% | ns |